Maxim Pharmaceuticals Inc (MAXM)

Not featured in screeners

Not featured in screeners

Ticker: MAXM Exchange: NMS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

GEHLSEN KURT R

Chief Scientific Officer

2 sales — total 355,688 USD

Sale 25 Jun 2004

Value US$612,685.28 | Price 106.24 | Shares 94,368

Sale 25 Jun 2004

Value US$1,770,689.90 | Price 277.70 | Shares 74,670

GEHLSEN KURT R

Chief Scientific Officer

1 sale — total 178,402 USD

Sale 24 Jun 2004

Value US$1,973,141.73 | Price 270.94 | Shares 20,326

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2004-06-28	2004-06-25	S Sale	GEHLSEN KURT R Chief Scientific Officer Officer	94,368 -33.1% 106.24 US$612,685	94,368 -33.1%	106.24	US$612,685
2004-06-28	2004-06-25	S Sale	GEHLSEN KURT R Chief Scientific Officer Officer	74,670 +49.6% 277.70 US$1,770,690	74,670 +49.6%	277.70	US$1,770,690
2004-06-28	2004-06-24	S Sale	GEHLSEN KURT R Chief Scientific Officer Officer	20,326 -46.7% 270.94 US$1,973,142	20,326 -46.7%	270.94	US$1,973,142

More insider trading research around Maxim Pharmaceuticals Inc